Copyright
©The Author(s) 2019.
World J Gastroenterol. Oct 7, 2019; 25(37): 5676-5686
Published online Oct 7, 2019. doi: 10.3748/wjg.v25.i37.5676
Published online Oct 7, 2019. doi: 10.3748/wjg.v25.i37.5676
Figure 2 Nonalcoholic fatty liver disease patients showed a significantly longer disease remission compared to inflammatory bowel disease patients without nonalcoholic fatty liver disease.
33.9 mo vs 21.14, P < 0.05.
- Citation: Magrì S, Paduano D, Chicco F, Cingolani A, Farris C, Delogu G, Tumbarello F, Lai M, Melis A, Casula L, Fantini MC, Usai P. Nonalcoholic fatty liver disease in patients with inflammatory bowel disease: Beyond the natural history. World J Gastroenterol 2019; 25(37): 5676-5686
- URL: https://www.wjgnet.com/1007-9327/full/v25/i37/5676.htm
- DOI: https://dx.doi.org/10.3748/wjg.v25.i37.5676